07 Jun Cellular Logistics one of five Business Plan Competition ventures with ties to UW-Madison
Five of the 13 finalists had roots at UW–Madison.
- Cellular Logistics: A spinoff from research by Eric Schmuck, Amish Raval and others at the Wisconsin Institutes of Medical Research, Cellular Logistics is advancing two heart-care products. One is a non-cell therapy, that, according to animal studies, restores the heart’s pumping function. The planned compound will be available on the shelf, ready to restore muscular function after heart attack. The second product is designed to aid stem-cell therapy to replace diseased heart muscle. Stem cells are typically washed out of the heart before they have time to produce muscle cells. Both products are designed to replace or augment stenting and/or heart drugs.